Literature DB >> 27590051

Generation and analyses of human synthetic antibody libraries and their application for protein microarrays.

Anna Säll1, Maria Walle1, Christer Wingren1, Susanne Müller2, Tomas Nyman3, Andrea Vala4, Mats Ohlin1, Carl A K Borrebaeck1, Helena Persson1.   

Abstract

Antibody-based proteomics offers distinct advantages in the analysis of complex samples for discovery and validation of biomarkers associated with disease. However, its large-scale implementation requires tools and technologies that allow development of suitable antibody or antibody fragments in a high-throughput manner. To address this we designed and constructed two human synthetic antibody fragment (scFv) libraries denoted HelL-11 and HelL-13. By the use of phage display technology, in total 466 unique scFv antibodies specific for 114 different antigens were generated. The specificities of these antibodies were analyzed in a variety of immunochemical assays and a subset was further evaluated for functionality in protein microarray applications. This high-throughput approach demonstrates the ability to rapidly generate a wealth of reagents not only for proteome research, but potentially also for diagnostics and therapeutics. In addition, this work provides a great example on how a synthetic approach can be used to optimize library designs. By having precise control of the diversity introduced into the antigen-binding sites, synthetic libraries offer increased understanding of how different diversity contributes to antibody binding reactivity and stability, thereby providing the key to future library optimization.
© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  affinity proteomics; phage display technology; protein microarrays; scFv; synthetic antibody libraries

Mesh:

Substances:

Year:  2016        PMID: 27590051     DOI: 10.1093/protein/gzw042

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  16 in total

1.  A Human IgE Antibody Binding Site on Der p 2 for the Design of a Recombinant Allergen for Immunotherapy.

Authors:  Jill Glesner; A Brenda Kapingidza; Magdalena Godzwon; Lesa R Offermann; Geoffrey A Mueller; Eugene F DeRose; Paul Wright; Crystal M Richardson; Judith A Woodfolk; Lisa D Vailes; Sabina Wünschmann; Robert E London; Martin D Chapman; Mats Ohlin; Maksymilian Chruszcz; Anna Pomés
Journal:  J Immunol       Date:  2019-09-25       Impact factor: 5.422

2.  Plasma protein profiling in a stage defined pancreatic cancer cohort - Implications for early diagnosis.

Authors:  Anna Sandström Gerdtsson; Christer Wingren; Helena Persson; Payam Delfani; Malin Nordström; He Ren; Xin Wen; Ulrika Ringdahl; Carl A K Borrebaeck; Jihui Hao
Journal:  Mol Oncol       Date:  2016-07-12       Impact factor: 6.603

3.  Generation and validation of recombinant antibodies to study human aminoacyl-tRNA synthetases.

Authors:  Charlotta Preger; Edvard Wigren; Elena Ossipova; Carolyn Marks; Johan Lengqvist; Camilla Hofström; Oskar Andersson; Per-Johan Jakobsson; Susanne Gräslund; Helena Persson
Journal:  J Biol Chem       Date:  2020-08-14       Impact factor: 5.157

4.  Identification of a serum biomarker signature associated with metastatic prostate cancer.

Authors:  Venera Kuci Emruli; Leena Liljedahl; Ulrika Axelsson; Corinna Richter; Lisa Theorin; Anders Bjartell; Hans Lilja; Jenny Donovan; David Neal; Freddie C Hamdy; Carl A K Borrebaeck
Journal:  Proteomics Clin Appl       Date:  2021-05-04       Impact factor: 3.603

5.  Tumor tissue protein signatures reflect histological grade of breast cancer.

Authors:  Petter Skoog; Mattias Ohlsson; Mårten Fernö; Lisa Rydén; Carl A K Borrebaeck; Christer Wingren
Journal:  PLoS One       Date:  2017-06-26       Impact factor: 3.240

6.  Advancing the immunoaffinity platform AFFIRM to targeted measurements of proteins in serum in the pg/ml range.

Authors:  Anna Säll; Daniel Corbee; Sara Vikström; Filip Ottosson; Helena Persson; Sofia Waldemarson
Journal:  PLoS One       Date:  2018-02-13       Impact factor: 3.240

7.  Circulating Levels of Interferon Regulatory Factor-5 Associates With Subgroups of Systemic Lupus Erythematosus Patients.

Authors:  Helena Idborg; Arash Zandian; Elena Ossipova; Edvard Wigren; Charlotta Preger; Fariborz Mobarrez; Antonio Checa; Azita Sohrabian; Pascal Pucholt; Johanna K Sandling; Cátia Fernandes-Cerqueira; Johan Rönnelid; Vilija Oke; Giorgia Grosso; Marika Kvarnström; Anders Larsson; Craig E Wheelock; Ann-Christine Syvänen; Lars Rönnblom; Kim Kultima; Helena Persson; Susanne Gräslund; Iva Gunnarsson; Peter Nilsson; Elisabet Svenungsson; Per-Johan Jakobsson
Journal:  Front Immunol       Date:  2019-05-17       Impact factor: 7.561

8.  SAMURAI (Solid-phase Assisted Mutagenesis by Uracil Restriction for Accurate Integration) for antibody affinity maturation and paratope mapping.

Authors:  Francis Jingxin Hu; Magnus Lundqvist; Mathias Uhlén; Johan Rockberg
Journal:  Nucleic Acids Res       Date:  2019-04-08       Impact factor: 16.971

Review 9.  Advances in the Production and Batch Reformatting of Phage Antibody Libraries.

Authors:  Rose H Reader; Robert G Workman; Ben C Maddison; Kevin C Gough
Journal:  Mol Biotechnol       Date:  2019-11       Impact factor: 2.695

10.  Institutional profile: the national Swedish academic drug discovery & development platform at SciLifeLab.

Authors:  Per I Arvidsson; Kristian Sandberg; Kjell S Sakariassen
Journal:  Future Sci OA       Date:  2017-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.